Serotonergic serotonin2 receptor modulation on DOPAC and 5-HIAA levels in rat striatum and nucleus accumbens: Microdialysis studies of freely moving rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 20, Issue 2, 1996, Pages 307-322

  Liu, Yia Ping ^a   Tseng, Ching Jiunn ^b   Huang, Nai Guei ^a   Yin, Tsai Hsin ^a   Tung, Che Se ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

5 HIAA; autoregulation; DOPAC; dopamine; microdialysis; nucleus accumbens; serotonin; striato nigral feedback loop; striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; APOMORPHINE; FENCLONINE; SEROTONIN; SEROTONIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; IN VIVO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; RAT; SEROTONINERGIC SYSTEM;

EID: 0029996358     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-5846(95)00312-6     Document Type: Article

References (39)

1. 2 Receptor Agonist, in Conscious rats. Eur. J. Pharmacol. 175: 323-332.
2. 3 Receptors in Rat Striatum. J. Pharmacol. Exp. Ther. 251: 803-809.
3. BUTCHER, S. P. and HAMBERGER, A. (1987) In Vivo Studies on the Extracellular, and Veratrine-Releasable, Pools of Endogenous Amino Acids in the Rat Striatum: Effects of Corticostriatal Deafferentation and Kainic Acid Lesion. J. Neurochem. 48: 713-721.
4. 3 Antagonist on Drug-Induced Stimulation of Dopamine Release. Eur. J. Pharmacol. 164: 515-519.
5. 3 Receptor by 1-Phenylbiguanide Increases Dopamine Release in the Rat Nucleus Accumbens. Brain. Res. 543: 354-357.
6. COOPER, J.R., BLOOM, F.E. and ROTH, R.H. (1991) Dopamine. In: The Biochemical Basis of Neuropharmacology, 6th ed., Copper, J.R., Bloom, F.E. and Roth, R.H. (Eds.), pp 285-337, Oxford University Press, New York.
7. DEMAREST, K. T., LAWSON-WEDDLING, K. L. and MOORE, K. E. (1983) d-Amphetamine and r-Butyrolactone Alteration of Dopamine Synthesis in the Terminals of Nigrostriatal and Mesolimbic Neurons. Biochem. Pharmacol. 32: 691-697.
8. DE SIMONI, M. G., DAL TOSO, G., FODRITTO, F., SOKOLA, A. and ALGERI, S. (1987) Modulation of Striatal Dopamine Metabolism by the Activity of Dorsal Raphe Serotonergic Afferences. Brain Res. 411: 81-88.
9. 2 Receptor Antagonist, Ritanserin, on Biogenic Amines in the Rat Nucleus Accumbens. Eur. J. Pharmacol. 192: 427-429.
10. GARRATT, J. C., KIDD, E. J., WRIGHT, I. K. and MARSDEN, C. A. (1991) Inhibition of 5-Hydroxytryptamine Neuronal Activity by the 5-HT Agonist, DOI. Eur. J. Pharmacol. 199: 349-355.
11. GRACE, A. A. (1991) Phasic Versus Tonic Dopamine Release and the Modulation of Dopamine System Responsivity: A Hypothesis for the Etiology of Schizophrenia. Neuroscience 41: 1-24.
12. GRENHOFF, J., UGEDO, L. and Svensson, T. H. (1988) Firing Patterns of Midbrain Dopamine Neurons: Differences Between A9 and A10 Cells. Acta Physiol. Scand. 134: 127-132.
13. HERVÉ D., PICKEL, V. M., JOH T. H. and BEAUDET A. (1987) Serotonin Axon Terminals in the Ventral Tegmental Area of the Rat: Fine Structure and Synaptic Input to Dopaminergic Neurons. Brain Res. 435: 71-83.
14. HOYER, D., CLARKE, D. E., FOZARD, J. R., HARTIG, P. R., MARTIN, G. R., MYLECHARANE, E. J., SAXENA, P.R. and HUMPHREY, P. P. A. (1994) International Union of Pharmacology Classification of Receptors for 5-Hydroxytryptamine. Pharmacol. Rev. 46: 157-203.
15. JACOBS, B. L. and AZMITIA, E. C. (1992) Structure and Function of the Brain Serotonin System. Physiol. Rev. 72: 165-229.
16. 2 Antagonistic Properties. J. Pharmacol. Exp. Ther. 244: 685-693.
17. KELLAND, M. D., FREEMAN, A. S. and CHIODO, L. A. (1990) Serotonergic Afferent Regulation of the Basic Physiology and Pharmacological Responsiveness of Nigrostriatal Dopamine Neurons. J. Pharmacol. Exp. Ther. 253: 803-811.
18. 3 Receptors in Rat Brain Using Radioligand Binding. Nature 330: 24-31.
19. KUCZENSKI, R. and SEGAL, D. (1989) Concomitant Characterization of Behavioral and Striatal Neurotransmitter Response to Amphetamine Using In Vivo Microdialysis. J. Neurosci. 9: 2051-2065.
20. LATEGAN, A. J., MARIEN, M. R. and COLPAERT, F. C. (1990) Effects of Locus Coeruleus Lesions on the Release of Endogenous Dopamine in the Rat Nucleus Accumbens and Caudate Nucleus as Determined by Intracerebral Microdialysis. Brain Res. 523: 134-138.
21. i Values. J. Pharmacol. Exp. Ther. 251: 238-246.
22. MELTZER, H. Y. and NASH, F. J. (1991) Effects of Antipsychotic Dugs on Serotonin Receptors. Pharmacol. Rev. 43: 587-604.
23. MOGHADDAM, B. and BUNNEY, B. S. (1990) Acute Effects of Typical and Atypical Antipsychotic Drugs on the Release of Dopamine from Prefrontal Cortex, Nucleus Accumbens, and Striatum of the Rat: An In Vivo Microdialysis Study. J. Neurochem 54: 1755-1760.
24. NOMIKOS, G. G., IURLO, M., ANDERSSON, J. L., KIMURA, K. and SVENSSON, T. H. (1994) Systemic Administration of Amperozide, a New Atypical Antipsychotic Drug, Preferentially Increases Dopamine Release in the Rat Medial Prefrontal Cortex Psychopharmacology 115: 147-156.
25. PAXINOS, G. AND WATSON, C. (1986) The Rat Brain in Stereotaxic Coordinates. 2nd ed., Academic Press, New York.
26. PAZOS, A., CORTÉS, R. and PALACIOS, J.M. (1985) Quantitative Autoradiographic Mapping of Serotonin Receptors in the Rat Brain. Brain Res. 346: 205-249.
27. REYNOLDS, G. P., RIEDERER, P., JELLINGER, K. and GABRIEL, E. (1981) Dopamine Receptors and Schizophrenia: the Neuroleptic Drug Problem. Neuropharmacology 20: 1319-1320.
28. 2 Receptor Agonist, in Conscious Rats. Eur. J. Pharmacol. 175: 323-332.
29. 3 Receptors. Trends Neurosci. 424-428.
30. SCHWARCZ, R. and COYLE, J. T. (1977) Striatal Lesions with Kainic Acid: Neurochemical Characteristics. Brain Res. 127: 235-249.
31. SKIRBOLL, L. R., GRACE, A. A. and BUNNEY, B. S. (1979) Dopamine Auto- and Postsynaptic Receptors: Electrophysiological Evidence for Differential Sensitivity to Dopamine Agonists. Science 206: 80-82.
32. SOGHOMONIAN, J. J., DOUCET, G. and DESCARRIES, L. (1987) Serotonin Innervation in Adult Rat Neostriatum. I. Quantified Regional Distribution. Brain Res. 425: 85-100.
33. 2 Receptor Antagonist, Activates Midbrain Dopamine Neurons by Blocking Serotonergic Inhibition. Psychopharmacology 98: 45-50.
34. WESTERINK, B. H. C., DAMSMA, G., ROLLEMA, H., DE VRIES, J. B. and HORN, A. S. (1987) Scope and Limitation of In Vivo Brain Dialysis: A Comparison of its Application to Various Neurotransmitter Systems. Life Sci 41: 1763-1776
35. WESTERINK, B. H. C. and DE VRIES, J. B. (1991) Effect of Precursor Loading on the Synthesis Rate and Release of Dopamine and Serotonin in the Striatum: a Microdialysis Study in Conscious Rats. J. Neurochem. 56: 228-233.
36. 3-Mediated Increase in Dopamine Transmission. J. Biomed. Sci. 2: 174-182.
37. ZETTERSTRÖM, T., SHARP, T., COLLIN, A. K. and UNGERSTEDT, U. (1988) In Vivo Measurement of Extracellular Dopamine and DOPAC in Rat Striatum After Various Dopamine-Releasing Drugs; Implications for the Origin of Extracellular DOPAC. Eur. J. Pharmacol. 148: 327-334.
38. ZETTERSTRÖM, T, SHARP, T. and UNGERSTEDT, U. (1984) Effect of Neuroleptic Drugs on Striatal Dopamine Release and Metabolism in the Awake Rat Studied by Intracerebral Dialysis. Eur. J. Pharmacol. 106: 27-37.
39. ZETTERSTRÖM, T. and UNGERSTEDT, U. (1984) Effects of Apomorphine on the In Vivo Release of Dopamine and its Metabolites, Studied by Brain Dialysis. Eur. J. Pharmacol. 97: 29-36.